MDM2 inhibitor SA53-OS
Term · Oncology and biomedicine · MLC-T-ONC-015044
An orally bioavailable inhibitor of murine double minute 2 (MDM2), with potential antineoplastic activity. Upon oral administration, MDM2 inhibitor A53-OS targets and binds to the MDM2 protein and prevents its binding to the transcriptional activation domain of the tumor suppressor protein p53. By preventing this MDM2-p53 interaction, the transcriptional activity of p53 is restored. This leads to p53-mediated induction of tumor cell apoptosis. MDM2, a zinc finger protein and a negative regulator of the p53 pathway, is overexpressed in cancer cells; it plays a key role in cancer cell proliferation and survival.
| Identifier | MLC-T-ONC-015044 |
|---|---|
| Field | Oncology and biomedicine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-015044",
"term": "MDM2 inhibitor SA53-OS",
"field": "Oncology and biomedicine",
"definition": "An orally bioavailable inhibitor of murine double minute 2 (MDM2), with potential antineoplastic activity. Upon oral administration, MDM2 inhibitor A53-OS targets and binds to the MDM2 protein and prevents its binding to the transcriptional activation domain of the tumor suppressor protein p53. By preventing this MDM2-p53 interaction, the transcriptional activity of p53 is restored. This leads to p53-mediated induction of tumor cell apoptosis. MDM2, a zinc finger protein and a negative regulator of the p53 pathway, is overexpressed in cancer cells; it plays a key role in cancer cell proliferation and survival.",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/mdm2-inhibitor-sa53-os/"
}
Record 10,704 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.